Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000903423-19-000202
Filing Date
2019-04-26
Accepted
2019-04-26 17:09:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 glaxo-tpti_13d.htm SC 13D 67196
  Complete submission text file 0000903423-19-000202.txt   68930
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Filed by) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Subject) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90986 | Film No.: 19772740
SIC: 2834 Pharmaceutical Preparations